7th ESCP 2026

Venue

Registration

Bogdan Budnik, Principal Scientist, Wyss Institute for Biologically Inspired Engineering, Boston, MA, USA; BD HPP Chair and EC member at HUPO

Bogdan has over 20 years of extensive experience in mass spectrometry-based proteomics analysis in the characterization of peptides and proteins utilizing a broad range of biological samples. At the Wyss Institute he helps to lead the Multi-omics Discovery Engine (MoDE) under the Diagnostics Accelerator (Wyss DxA) with the goal of catalyzing innovation in the fields of therapeutics and diagnostics. During the last 15 years, prior to this role at the Wyss, he was the Director of the Proteomics Laboratory at Harvard University supporting a variety of scientific projects for the larger Harvard community and its associated researchers.

Tine Claeys, Post-doctoral researcher – Compomics – VIB-Ugent Center for Medical Biotechnology, UGent, Belgium

During her PhD Tine mainly focused on the reuse of public proteomics data to uncover tissue-specific protein and PTM patterns from a machine learning perspective, before she joined the group of Lennart Martens for her Post Doc to develop the bioinformatics components needed to enable sensitive DIA for tissue leakage proteins. In parallel, she is engaging the proteomics community to improve metadata annotation and the AI-oriented reusability of public proteomics data.

Vadim Demichev, MSTARS Group Leader at Charité, Berlin, Germany

Expert for high-throughput proteomics and author of DIA-NN. In 2024 he co-founded Aptila Biotech, a DIA-NN Enterprise aiming to keep advancing LC-MS proteomics as a reliable and streamlined technology that ensures quantitative accuracy.

Qun Fang, Dishtinguished Professor in the Department of Chemistry at Zhejiang University, and the Director of Institute of Microanalytical Systems at Zhejiang University, Hangzhou, China

His research interests focuses on droplet-based microfluidic analysis, microfluidic mass spectrometry, capillary electrophoresis and liquid chromatographic analysis, miniaturization of analytical instruments, and the application of these techniques and systems in single cell analysis, high-throughput screening, biochemical analysis, clinical diagnosis, and point-of-care testing. He has published more than 120 peer-reviewed papers in these areas, and has 22 patents issued in the area of microfluidics. He is the recipient of the China National Funds for Distinguished Young Scientists (2008) and the Liang Shu-Quan Award for Fundamental Research in Analytical Chemistry by Chinese Chemical Society (2015). 

Tami Geiger, Associate Professor at the Weizmann Institute of Science, Rehovot, Israel

Tami develops novel single cell proteomic approaches, and combines them with tumor analyses and bioinformatics to characterize cellular interactions within the tumor microenvironment, and how these interactions associate with response to immunotherapy. Her lab further investigates the association between the proteomic level and the genomic and transcriptomic levels aiming to elucidate gene-expression regulatory mechanisms and the functional proteomic output of cancer somatic mutations.

Alexander Ivanov, Associate Professor at Northeastern University – Boston, MA, USA

Alexander earned his Ph.D. in Bioorganic Chemistry at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow in 2000 before starting a postdoc at Northeastern University. He later joined Harvard University and became Director of the HSPH Proteomic Resource in 2008, before rejoining Northeastern, where he is currently working as Associate Professor at the Department of Chemistry & Chemical Biology Alexander’s research interests include characterization of PTMs and protein isoforms, deep proteomics profiling of limited biological samples, ultra-low flow separation techniques such as capillary electrophoresis and extracellular vesicle analysis.

Ryan T. Kelly, Full Professor at Brigham Young University – Provo, UT, USA

Ryan received his Ph.D. in analytical chemistry from BYU in 2005 before spending the next 13 years at PNNL, ultimately serving as Senior Research Scientist, Manager and Chief Technologist for EMSL, a national scientific user facility at PNNL, where he developed the popular nanoPOTS platform. Ryan is (co-)author of >100 publications, has won several awards and is named inventor on a number of licensed and commercialized patents. He focuses on technological improvements for ultrasensitive proteomic analyses and is currently Associate Professor at BYU.

Adriana F. Paes Leme, Brazilian Biosciences National Laboratory, Campinas, Brasil

Adriana F. Paes Leme received her Ph.D. from the State University of Campinas, Brazil, before conducting postdoctoral research at the Butantan Institute in São Paulo, Brazil, and the University of Virginia School of Medicine, VA, USA. Since 2009, she has been a Principal Investigator and Head of the Mass Spectrometry Facility at the Brazilian Biosciences National Laboratory (LNBio), part of the Brazilian Center for Research in Energy and Materials (CNPEM). Her research focuses on advancing mass spectrometry-based proteomics to understand diverse microenvironments, primarily in head and neck cancer, with a particular emphasis on biofluid proteomics, spatial proteomics, and, more recently, single-cell proteomics. 

Florian Rosenberger, Karolinska Institute, Stockholm, Sweden

Florian Rosenberger works as Assistant Professor at the Karolinska Institute. Before he was working with Prof. Matthias Mann as EMBO postdoctoral fellow at the Max Planck Institute of Biochemistry in Martinsried, Germany. He holds a PhD in mitochondrial biology from the Karolinska Institute. Florian’s research in the field of MS-based single cell proteomics centers around understanding the metabolic niches in both healthy and diseased contexts. His work primarily focuses on liver biology, encompassing the development of a single-cell proteomics map to unravel the spatially dependent proteome of hepatocytes.